Trial intelligence / Profile preview

G-CSF for Prevention of Nosocomial Infections in Neutropenic Prematures

NCT00213759Phase 3Completed

Sponsor
Strasbourg University Hospital
Start
Mar 2002
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 3 trial of filgrastim in neutropenia, sponsored by Strasbourg University Hospital. Started Mar 2002; status: completed.

02

Drugs

filgrastim
03

Conditions

neutropenia

Beyond the preview

Go deeper on NCT00213759.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00213759.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call